mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0005 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.19 |
0.001 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.001 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |